Vablys® dosing and administration
convenient once-daily dosing to help promote compliance1
- One Vablys® tablet intravaginally at bedtime for six consecutive days1
- Please see Product Monograph for complete dosing and administration information1
Dosing Consideration
The following recommendations should be considered during treatment with Vablys®:
- Since heavy bleeding during menses could result in a wash-out, the required local concentrations of dequalinium chloride cannot be ensured. Thus, it is recommended to start therapy 6 days before the next menses or directly after menses. In the event the treatment cannot be completed before the onset of menses, treatment should be interrupted and resumed afterwards.
- Treatment should be continued for six consecutive days even when subjective discomfort (itching, discharge, odour) has resolved. Treatment for less than six days could result in increased risk of relapse.
- There are no data regarding the effect of sexual intercourse on the efficacy of Vablys®. It is recommended to refrain from sexual intercourse during treatment with Vablys®.
- Insufficient data are available to Health Canada regarding the compatibility of Vablys® with condoms and other intravaginal devices and genitourinary products (e.g., diaphragms, menstrual tampons and cups, soaps, spermicides, vaginal douches (vaginal washes), natural health, herbal, cosmetic, etc.). The concomitant use of condoms and other intravaginal and genitourinary devices and products is not recommended.
For complete dosage and administration information, please see the Product Monograph.